| HealthPartners | Hematopoietic stem cell mobilizers | 2025-04-01 |
| HealthPartners | Lefamulin (Xenleta™) – Minnesota Health Care | 2025-04-01 |
| HealthPartners | Lifileucel (Amtagvi™) | 2025-04-01 |
| HealthPartners | Lumasiran (Oxlumo™) | 2025-04-01 |
| HealthPartners | Ocular complement inhibitors | 2025-04-01 |
| HealthPartners | Oncology - atezolizumab (Tecentriq®) – Minnesota | 2025-04-01 |
| HealthPartners | Oncology - avelumab (Bavencio®) – Minnesota Health | 2025-04-01 |
| HealthPartners | Oncology - caplacizumab-yhdp (Cablivi®) | 2025-04-01 |
| HealthPartners | Oncology - emapalumab-lzsg (Gamifant®) | 2025-04-01 |
| HealthPartners | Oncology - enfortumab vedotin-ejfv (Padcev™) – | 2025-04-01 |